Nuvalent Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

13

NUVL
Nuvalent

Last Price:

$84.24

Seasonality Move:

-15.75%

Sell

19

NBY
NovaBay Pharmaceuticals

Last Price:

$0.53

Seasonality Move:

-0.66%

Sell

13

Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

The current Nuvalent [NUVL] share price is $84.15. The Score for NUVL is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
NUVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

19

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

The Nuvalent share price today is $84.15

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUVL is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.53

The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUVL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.38	Sell
Relative Strength Index (14 RSI):	32.82	Sell
Chaikin Money Flow:	-422133	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(87.16 - 95.48)	Sell
Bollinger Bands (100):	(80.6 - 101.04)	Sell

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.04	Sell
Relative Strength Index (14 RSI):	39.44	Sell
Chaikin Money Flow:	514099	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.53 - 0.67)	Sell
Bollinger Bands (100):	(0.49 - 0.69)	Sell

NUVL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	86.87	Sell
20-day SMA:	91.67	Sell
50-day SMA:	93.34	Sell
200-day SMA:	82.44	Buy
8-day EMA:	86.79	Sell
20-day EMA:	89.72	Sell
50-day EMA:	91.69	Sell
200-day EMA:	83.59	Buy

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.54	Sell
20-day SMA:	0.57	Sell
50-day SMA:	0.63	Sell
200-day SMA:	1.88	Sell
8-day EMA:	0.54	Sell
20-day EMA:	0.57	Sell
50-day EMA:	0.64	Sell
200-day EMA:	4.7	Sell

Nuvalent Earnings Growth & NUVL Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.61 per share, and a decrease next year of $0.69 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Nuvalent Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):